Fulcrum Therapeutics Inc

NASDAQ:FULC   3:59:54 PM EDT
7.42
-0.34 (-4.38%)
Earnings Announcements

Fulcrum Therapeutics Reports Recent Business Highlights And First Quarter 2022 Financial Results

Published: 05/09/2022 13:46 GMT
Fulcrum Therapeutics Inc (FULC) - Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results.
Fulcrum Therapeutics - Cash Runway Into 2024.
Qtrly Net Loss per Share, Basic and Diluted $0.64.
Q1 Earnings per Share View $-0.63 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $2.96 Million
Adjusted EPS is expected to be -$0.66

Next Quarter Revenue Guidance is expected to be $3.11 Million
Next Quarter EPS Guidance is expected to be -$0.69

More details on our Analysts Page.